Anacetrapib (USAN, pINN; codenamed MK-0859, Merck) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.

CAS：875446-37-0
中文别名：
英文别名：MK-0859;UNII-P7T269PR6S;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one;
分子式：C30H25F10NO3
分子量：637.508
精确质量：637.167
Psa：38.77
Logp：9.701

UNII：P7T269PR6S